Prediction models for liver decompensation in compensated advanced chronic liver disease: a systematic review

Hepatology

Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study

Lancet Gastroenterol Hepatol

Jachs M, Odriozola A, Turon F, Moga L, Téllez L, Fischer P, Saltini D, Kwanten WJ, Grasso M, Llop E, Mendoza YP, Armandi A, Thalhammer J, Pardo C, Colecchia A, Ravaioli F, Maasoumy B, Laleman W, Presa J, Schattenberg JM, Berzigotti A, Calleja JL, Calvaruso V, Francque S, Schepis F, Procopet B, Albillos A, Rautou PE, García-Pagán JC, Puente Á, Fortea JI, Reiberger T, Mandorfer M, SSM-100Hz/ACLD Study Group, Baveno Cooperation

doi: 10.1016/S2468-1253(24)00234-6

Hepatology

Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure

Hepatology

Semmler G, Alonso López S, Pons M, Lens S, Dajti E, Griemsmann M, Zanetto A, Burghart L, Hametner-Schreil S, Hartl L, Manzano M, Rodriguez-Tajes S, Zanaga P, Schwarz M, Gutierrez ML, Jachs M, Pocurull A, Polo B, Ecker D, Mateos B, Izquierdo S, Real Y, Balcar L, Carbonell-Asins JA, Gschwantler M, Russo FP, Azzaroli F, Maasoumy B, Reiberger T, Forns X, Genesca J, Bañares R, Mandorfer M

doi: 10.1097/HEP.0000000000001005

Hepatology

Epidemiology of compensated Advanced Chronic Liver Disease (cACLD) in the United States: Insights from NHANES 2017-2020

Clin Gastroenterol Hepatol

Goyal RM, Doshi A, Rao S, Arora K, Maheshwari S, Gaglio P

doi: 10.1016/j.cgh.2025.06.010

Hepatology

Effectiveness of a model of care based on Fibrosis-4 and liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk of advanced liver disease: results from an Italian prospective multicentre study

Am J Gastroenterol

Caviglia GP, Ferro A, D'Ambrosio R, Perbellini R, Lampertico P, Periti G, Valenti L, Ciccioli C, Pennisi G, Petta S, Brodosi L, Petroni ML, Marchignoli F, Pironi L, Sagripanti A, Argenziano ME, Svegliati-Baroni G, Rosso C, Barutta F, Armandi A, Gruden G, Bugianesi E

doi: 10.14309/ajg.0000000000003493

Hepatology

Social Determinants of Health Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence and Severity: A Systematic Review and Meta-analysis

Am J Gastroenterol

Abu-Rumaileh M, Dhoop S, Pace J, Qapaja T, Martinez ME, Tincopa M, Loomba R

doi: 10.14309/ajg.0000000000003421

Celiac Disease

Association between celiac disease and risk of kidney diseases: a systematic review and meta-analysis

Minerva Gastroenterol (Torino)

Rathore SS, Shaikh SP, Zaidi HR, Salako GO, Saravanan CR, Kuranga RR, Yagateela N, Bandala ST, Jeswani BM

doi: 10.23736/S2724-5985.25.03733-7

Hepatology

From "Burnt-Out" to "Burning-Out": Capturing Liver Fat Loss in Patients with Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease from A Dynamic Perspective

Gastroenterology

Liu WY, Huang S, Ji H, Kim SU, Cheuk-Fung Yip T, Lai-Hung Wong G, Petta S, Tsochatzis E, Nakajima A, Bugianesi E, George Goh BB, Chan WK, Romero-Gomez M, Sanyal AJ, Boursier J, Hagström H, Calleja JL, de Lédinghen V, Newsome PN, Fan JG, Lai M, Castéra L, Lee HW, Pennisi G, Yoneda M, Armandi A, Kim-Jun Teh K, Gallego-Durán R, Asgharpour A, de Saint-Loup M, Shang Y, Llop E, Fournier C, Mahgoub S, Lara-Romero C, Canivet CM, Sau-Wai Chan M, Lin H, Chen LL, Targher G, Byrne CD, Du M, Wai-Sun Wong V, Zheng MH, VCTE-Prognosis Study Group

doi: 10.1053/j.gastro.2025.02.034

Further Publications

Screening for advanced liver fibrosis due to metabolic dysfunction-associated steatotic liver disease alongside retina scanning in people with type 2 diabetes: a cross-sectional study

Lancet Gastroenterol Hepatol

Lindfors A, Strandberg R, Hagström H

doi: 10.1016/S2468-1253(24)00313-3

HepatologyFurther Publications

Prior metabolic and bariatric surgery is an independent determinant of severity of decompensation in alcohol-associated liver disease

United European Gastroenterol J

Onghena L, van Nieuwenhove Y, Van Vlierberghe H, Devisscher L, Raevens S, Verhelst X, Lefere S, Geerts A

doi: 10.1002/ueg2.12642

Related content

Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study

Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure

Epidemiology of compensated Advanced Chronic Liver Disease (cACLD) in the United States: Insights from NHANES 2017-2020

Effectiveness of a model of care based on Fibrosis-4 and liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk of advanced liver disease: results from an Italian prospective multicentre study

Social Determinants of Health Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence and Severity: A Systematic Review and Meta-analysis

Association between celiac disease and risk of kidney diseases: a systematic review and meta-analysis

From "Burnt-Out" to "Burning-Out": Capturing Liver Fat Loss in Patients with Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease from A Dynamic Perspective

Screening for advanced liver fibrosis due to metabolic dysfunction-associated steatotic liver disease alongside retina scanning in people with type 2 diabetes: a cross-sectional study

Prior metabolic and bariatric surgery is an independent determinant of severity of decompensation in alcohol-associated liver disease